Company Name: |
Borenpharm Co., Ltd
|
Tel: |
027-65563561 |
Email: |
sales@borenpharm.com |
Products Intro: |
Product Name:Propargyl-PEG6-bromide Purity:95% HPLC Package:1g; 5g
|
Propargyl-PEG6-Br manufacturers
- Propargyl-PEG6-bromide
-
- $0.00 / 1g
-
2024-03-26
- CAS:1973383-30-0
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| Propargyl-PEG6-Br Basic information |
Product Name: | Propargyl-PEG6-Br | Synonyms: | Propargyl-PEG6-Br;Propargyl-PEG6-bromide;1-bromo-3,6,9,12,15,18-hexaoxahenicos-20-yne;Propargyl-PEG6-Br/3,6,9,12,15,18-Hexaoxaheneicos-20-yne, 1-bromo-;3,6,9,12,15,18-Hexaoxaheneicos-20-yne, 1-bromo- | CAS: | 1973383-30-0 | MF: | C15H27BrO6 | MW: | 383.28 | EINECS: | | Product Categories: | | Mol File: | 1973383-30-0.mol | |
| Propargyl-PEG6-Br Chemical Properties |
Boiling point | 417.7±40.0 °C(Predicted) | density | 1.231±0.06 g/cm3(Predicted) |
| Propargyl-PEG6-Br Usage And Synthesis |
Biological Activity | Propargyl-PEG6-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| Propargyl-PEG6-Br Preparation Products And Raw materials |
|